Acumen Hypotension Prediction Index (HPI) Feature Software vs ASSURE Wearable ECG
AI Verdict
Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…
Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your primary need is real-time, predictive monitoring to proactively prevent and manage hypotensive events in critically ill or surgical patients. This tool is ideal for settings where early detection of hemodynamic instability, up to 15 minutes before it occurs, is crucial for improving patient outcomes through timely intervention.
View Acumen Hypotension Prediction Index (HPI) Feature Software →Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients in an outpatient or remote setting. This wearable device is best suited for identifying cardiac trends, automatically storing episodes, and providing alert-based notifications to clinicians for ongoing patient management outside of acute care.
View ASSURE Wearable ECG →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | ASSURE Wearable ECG |
|---|---|---|
| Pricing | Unknown | Contact for pricing. |
| Deployment | Unknown | Wearable device, mobile application, and cloud-based remote patient data platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGTool B, the ASSURE Wearable ECG, focuses on patient usability with its comfortable SensorFit Garment and mobile application, making continuous monitoring accessible for at-risk cardiac patients. While Tool A integrates into existing critical care workflows for clinicians, Tool B's design prioritizes ease of use for the patient in a remote monitoring context.
Clinical Value
Acumen Hypotension Prediction Index (HPI) Feature SoftwareTool A, Acumen HPI, offers a strong and specific clinical value proposition by demonstrating a reduction in the incidence, duration, and severity of intraoperative hypotension. This direct impact on patient outcomes through proactive hemodynamic management is explicitly stated. Tool B provides valuable continuous monitoring data, but the provided information does not quantify its direct impact on clinical outcomes in the same way.
Pricing & Value
TieBoth Tool A and Tool B state that pricing information is not publicly available and requires contacting the vendor. Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their relative pricing and value.
Enterprise Readiness
Acumen Hypotension Prediction Index (HPI) Feature SoftwareTool A is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, a widely adopted system in acute care settings, indicating strong readiness for deployment within existing hospital infrastructure. Both tools are FDA cleared, HIPAA compliant, and have BAAs, but Tool A benefits from being part of a larger, established enterprise ecosystem with extensive hospital presence.
Innovation
Acumen Hypotension Prediction Index (HPI) Feature SoftwareTool A is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotensive events up to 15 minutes before they occur, representing a significant advancement in proactive critical care. While Tool B features innovative elements for a wearable ECG, the predictive analytics of Tool A for a critical, time-sensitive physiological event stands out as more groundbreaking.
Support & Docs
Acumen Hypotension Prediction Index (HPI) Feature SoftwareEdwards Lifesciences, the company behind Acumen HPI, is a large and established medical device manufacturer known for its comprehensive clinical education, technical support, and extensive documentation for its products. While Kestra Medical Technologies also provides support for its wearable, the breadth and depth of support from a major enterprise like Edwards are generally more robust and readily available for clinicians.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | ASSURE Wearable ECG |
|---|---|---|
| Name | Acumen Hypotension Prediction Index (HPI) Feature Software | ASSURE Wearable ECG |
| Company | Edwards Lifesciences | Kestra Medical Technologies |
| Description | Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes. | Kestra Medical Technologies offers the ASSURE Wearable ECG, a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. |
| Categories | Cardiology AI, Triage & ER/ICU AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Anesthesiology, Critical Care, Emergency Medicine | Cardiology |
| Key Features (Example 1) | Hypotension Prediction Index (HPI) parameter (0-100 score) | Wearable ECG device for continuous heart rate monitoring |
| Key Features (Example 2) | Predicts hypotension up to 15 minutes before an event | SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors |
| Key Features (Example 3) | Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring | Kestra CareStation remote patient data platform for clinician review |
Videos
Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and ASSURE Wearable ECG.